Annual Total Expenses
$110.49 M
-$49.59 M-30.98%
31 December 2023
Summary:
Y-mAbs Therapeutics annual total expenses is currently $110.49 million, with the most recent change of -$49.59 million (-30.98%) on 31 December 2023. During the last 3 years, it has fallen by -$30.19 million (-21.46%). YMAB annual total expenses is now -30.98% below its all-time high of $160.08 million, reached on 31 December 2022.YMAB Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$27.03 M
-$5.56 M-17.06%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly total expenses is currently $27.03 million, with the most recent change of -$5.56 million (-17.06%) on 30 September 2024. Over the past year, it has dropped by -$1.17 million (-4.16%). YMAB quarterly total expenses is now -46.73% below its all-time high of $50.74 million, reached on 30 June 2022.YMAB Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.0% | -4.2% |
| 3 y3 years | -21.5% | -28.3% |
| 5 y5 years | +155.6% | +11.0% |
YMAB Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.0% | at low | -46.7% | +1.8% |
| 5 y | 5 years | -31.0% | +155.6% | -46.7% | +13.8% |
| alltime | all time | -31.0% | +548.5% | -46.7% | +603.5% |
Y-mAbs Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $27.03 M(-17.1%) |
| June 2024 | - | $32.59 M(+21.4%) |
| Mar 2024 | - | $26.84 M(+1.0%) |
| Dec 2023 | $110.49 M(-31.0%) | $26.56 M(-5.8%) |
| Sept 2023 | - | $28.20 M(+0.8%) |
| June 2023 | - | $27.97 M(+0.8%) |
| Mar 2023 | - | $27.75 M(-14.9%) |
| Dec 2022 | $160.08 M(+6.5%) | $32.60 M(-15.4%) |
| Sept 2022 | - | $38.55 M(-24.0%) |
| June 2022 | - | $50.74 M(+32.9%) |
| Mar 2022 | - | $38.18 M(-15.8%) |
| Dec 2021 | $150.33 M(+6.9%) | $45.36 M(+20.4%) |
| Sept 2021 | - | $37.67 M(+11.9%) |
| June 2021 | - | $33.66 M(+0.1%) |
| Mar 2021 | - | $33.64 M(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $140.69 M(+69.5%) | $40.84 M(+25.1%) |
| Sept 2020 | - | $32.64 M(-19.3%) |
| June 2020 | - | $40.45 M(+51.2%) |
| Mar 2020 | - | $26.75 M(+12.6%) |
| Dec 2019 | $83.00 M(+92.0%) | $23.76 M(-2.5%) |
| Sept 2019 | - | $24.36 M(+30.7%) |
| June 2019 | - | $18.63 M(+14.6%) |
| Mar 2019 | - | $16.25 M(+15.4%) |
| Dec 2018 | $43.23 M(+124.6%) | $14.08 M(+23.3%) |
| Sept 2018 | - | $11.41 M(+11.3%) |
| June 2018 | - | $10.26 M(+37.2%) |
| Mar 2018 | - | $7.48 M(-19.4%) |
| Dec 2017 | $19.24 M(+12.9%) | $9.28 M(+141.4%) |
| Sept 2017 | - | $3.84 M |
| Dec 2016 | $17.04 M | - |
FAQ
- What is Y-mAbs Therapeutics annual total expenses?
- What is the all time high annual total expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual total expenses year-on-year change?
- What is Y-mAbs Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly total expenses year-on-year change?
What is Y-mAbs Therapeutics annual total expenses?
The current annual total expenses of YMAB is $110.49 M
What is the all time high annual total expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual total expenses is $160.08 M
What is Y-mAbs Therapeutics annual total expenses year-on-year change?
Over the past year, YMAB annual total expenses has changed by -$49.59 M (-30.98%)
What is Y-mAbs Therapeutics quarterly total expenses?
The current quarterly total expenses of YMAB is $27.03 M
What is the all time high quarterly total expenses for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly total expenses is $50.74 M
What is Y-mAbs Therapeutics quarterly total expenses year-on-year change?
Over the past year, YMAB quarterly total expenses has changed by -$1.17 M (-4.16%)